Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-08-14

FDA Approved: TRETINOIN — Original Application (Alembic Pharmaceuticals Inc.)

View source ↗

Summary

FDA approves Alembic Pharmaceuticals' generic topical tretinoin through an Original Application (ANDA). The product is indicated for acne vulgaris.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tretinoin (generic) (tretinoin)

Snippet

ORIG AP for TRETINOIN (TRETINOIN)